Intelligence · Clinical Development
Pipeline search results
Programs matching “healthy” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 1,124 pipeline programs matching "healthy" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
GLPG0492
Lakefront Biotherapeutics NV
Healthy
3 trials -
GLPG0555
Lakefront Biotherapeutics NV
Healthy
2 trials -
GLPG0555 solid dispersion
Lakefront Biotherapeutics NV
Healthy
1 trial -
GLPG0634
Lakefront Biotherapeutics NV
Healthy
3 trials -
GLPG0634 100mg capsule once a day for 10 days
Lakefront Biotherapeutics NV
Healthy
1 trial -
GLPG0634 50 mg
Lakefront Biotherapeutics NV
Healthy
1 trial -
GLPG0778
Lakefront Biotherapeutics NV
Healthy
2 trials -
GLPG0974
Lakefront Biotherapeutics NV
Healthy
2 trials -
GLPG1205
Lakefront Biotherapeutics NV
Healthy
2 trials -
GLPG1205 50mg q.d.
Lakefront Biotherapeutics NV
Healthy
1 trial -
GLPG1205 film-coated tablets
Lakefront Biotherapeutics NV
Healthy
1 trial -
GLPG1205 single ascending doses, oral suspension
Lakefront Biotherapeutics NV
Healthy
1 trial -
GLPG1690
Lakefront Biotherapeutics NV
Healthy
2 trials -
GLPG1690 film-coated tablets
Lakefront Biotherapeutics NV
Healthy
1 trial -
GLPG1690 single ascending doses
Lakefront Biotherapeutics NV
Healthy
1 trial -
GLPG1837 500 mg
Lakefront Biotherapeutics NV
Healthy
1 trial -
GLPG1837 single ascending doses
Lakefront Biotherapeutics NV
Healthy
1 trial -
GLPG1972
Lakefront Biotherapeutics NV
Healthy
1 trial -
GLPG1972 - A
Lakefront Biotherapeutics NV
Healthy
1 trial -
GLPG1972 film-coated tablets
Lakefront Biotherapeutics NV
Healthy
1 trial -
GLPG1972 single ascending doses
Lakefront Biotherapeutics NV
Healthy
1 trial -
GLPG2222 single dose
Lakefront Biotherapeutics NV
Healthy
1 trial -
GLPG2451 multiple dose
Lakefront Biotherapeutics NV
Healthy
1 trial -
GLPG2451 single dose
Lakefront Biotherapeutics NV
Healthy
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.